KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹17 Cr | ₹18 Cr | ₹20 Cr | ₹41 Cr | ₹21 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹21 Cr |
How is Contingent Liabilities of KOPRAN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | -5.24 | |
| Mar2024 | ₹18 Cr | -9.05 | |
| Mar2023 | ₹20 Cr | -51.22 | |
| Mar2022 | ₹41 Cr | 93.30 | |
| Mar2021 | ₹21 Cr | - | |
Compare Contingent Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹725.9 Cr | 17.4% | 15.8% | -29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 17.4% |
15.8% |
-29.3% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses